Valbiotis Balance Sheet Health
Financial Health criteria checks 3/6
Valbiotis has a total shareholder equity of €11.7M and total debt of €5.1M, which brings its debt-to-equity ratio to 43.8%. Its total assets and total liabilities are €24.9M and €13.3M respectively.
Key information
43.8%
Debt to equity ratio
€5.12m
Debt
| Interest coverage ratio | n/a |
| Cash | €13.74m |
| Equity | €11.68m |
| Total liabilities | €13.26m |
| Total assets | €24.94m |
Financial Position Analysis
Short Term Liabilities: ALVAL's short term assets (€22.1M) exceed its short term liabilities (€7.6M).
Long Term Liabilities: ALVAL's short term assets (€22.1M) exceed its long term liabilities (€5.6M).
Debt to Equity History and Analysis
Debt Level: ALVAL has more cash than its total debt.
Reducing Debt: ALVAL's debt to equity ratio has increased from 19.9% to 43.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ALVAL has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ALVAL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.